Resources for LF Dossier Elimination

Guidelines & Reports

Title	Year	Purpose
Validation of elimination of lymphatic filariasis as a public health problem	2017	These standard operating procedures are intended for use when a Member State wishes to request validation of national elimination of lymphatic filariasis as a public health problem following implementation of interventions to achieve the aims of the Global Programme.
Navigating the Path to Elimination: Lessons from Lymphatic Filariasis and Trachoma Dossiers	2024	This technical brief provides a summary of best practices and common challenges for countries preparing LF and trachoma dossiers—lessons gathered from dossier submission work in Act \| East supported countries.
WHO LF Dossier Narrative template	2026	This Word document provides a template for national LF programmes to use to write their LF elimination dossiers. (version February 2026)
WHO LF Dossier Data Annex	2026	This Excel document provides a template for national LF programmes to use to compile and submit data for their LF elimination dossiers. Not yet released
LF Dossier Job Aid	2018	A two-page job aid highlighting what information is needed for the LF elimination dossier and how to submit it.
FAQ (March 2026)	2026	This Frequently Asked Questions document compiles answers to questions asked during the LF Dossier Development webinar in March 2026

Resources

Maps & Data

Access thematic maps and datasets on lymphatic filariasis endemicity and treatment implementation

CHIP Dashboards

An innovative solution designed to address the critical need of NTD Programme Managers for tracking programmatic activities across multiple reporting periods.

Meeting Reports & News

8 April 2026 Lessons Learned in LF Dossier Development Webinar: Strengthening Readiness for Validation

ESPEN and Sightsavers co-hosted a regional webinar in March 2026 to share lessons learned in lymphatic filariasis (LF) dossier development and strengthen country readiness for validation. The session highlighted the importance of early, continuous documentation and alignment with WHO guidance to support a smooth validation process. Key insights and practical recommendations are now available to guide countries progressing toward elimination of LF as a public health problem.

Article